Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Book Chapter from CEM on Microwave Peptide Synthesis

Published: Monday, June 17, 2013
Last Updated: Monday, June 17, 2013
Bookmark and Share
Contribution of new chapter appears in Microwaves in Organic Synthesis, Volume 2.

CEM Corporation has announced its contribution of a new chapter on microwave peptide synthesis, which appears in Microwaves in Organic Synthesis, Volume 2, Third Edition, edited by Professor Antonio de la Hoz and Dr. André Loupy.

The chapter entitled, “Microwave-Enhanced Synthesis of Peptides, Proteins and Peptidomimetics,” was authored by Jonathan M. Collins, the initial developer of CEM’s microwave peptide synthesis technology, and offers an in-depth discussion of the theory, technology, and chemistry behind incorporating microwave energy into peptide synthesis with more than 300 cited references.

It provides a complete overview and analysis of all research to date in this field along with a mechanistic discussion of the common chemistries and side reactions encountered in solid phase peptide synthesis.

“This chapter is intended to be a useful tool for any researcher using or considering using microwave irradiation for solid phase synthesis of peptides and peptidomimetics” said Jonathan M. Collins, “The field is rapidly evolving and microwave has proven useful for reducing synthesis times as well as in many cases increasing peptide product purity.”

Collins, who holds degrees from the University of Florida, Northwestern University, and Stanford University, initiated CEM’s movement into microwave peptide synthesis in late 2002.

Currently, Director of Business Development for CEM Corporation, Collins continues to research microwave peptide synthesis and develop new methods and technologies to improve the process.

In 2013, CEM plans to announce several major developments in microwave peptide synthesis that will continue its leadership position in this field.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Prof. Steven Ley to Speak at the International Microwaves in Chemistry Conference
Dr. Ley, a BP Professor of Organic Chemistry at the University of Cambridge and a Fellow of Trinity College, will be the Keynote Speaker for the 2007 conference in London.
Thursday, January 18, 2007
Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!